Each month, we compile and present a comprehensive up-to-date list of recently started clinical trials to keep you informed of the latest advancements and research in the medical field. To be the first to know about new clinical trials Register Now for free

The below are the clinical trials posted for the first time in August 2024.

Phase 4:

  1. A Biomarker Exploratory Study of Dual Blockade of PD1/PDL1 and CTLA4 and Anti-angiogenic Therapy
  2. A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features
  3. Exploration of Dalpiciclib + Tucidinostat in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor
  4. A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results
  5. Merck Belzutifan PAS
  6. Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
  7. Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
  8. Ileal Reservoir Length and Functional Outcome in Ileal Pouch-anal Anastomosis: An Assessor-blinded, Randomized Controlled Trial
  9. Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France

Phase 3:

  1. Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors
  2. A Study of ES014 in Subjects With Advanced Solid Tumors
  3. D20054
  4. Effect of Silkworm Pupa Tablets in Gastrointestinal Malignancies at Nutritional Risk Following Radical Surgery
  5. Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab
  6. Earlier Detection and Optimization of Treatment and Prognosis for Patients with Early-onset Colorectal Cancer
  7. Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis
  8. A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naΓ―ve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
  9. Evaluation of CMV/EBV-CMI in Haploid HSCT
  10. CEB-01 in Locally Resectable Pancreatic Cancer
  11. A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
  12. Brief Title: Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
  13. Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients
  14. ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
  15. Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer
  16. Intra-operative Air Leak Management After Minimally Invasive Lung Segmental Resection
  17. EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
  18. Using the Epitranscriptome to Diagnose and Treat Gliomas
  19. Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
  20. Searching for Predictive Biomarkers of Efficacy in Small Cell Lung Cancer Patients Treated With Chemotherapy-immunotherapy Combination Using Imaging Mass Cytometry (HYPE)
  21. Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients
  22. Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
  23. Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma
  24. Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia
  25. Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
  26. Emapalumab Prevention of CAR-T Cell Associated Toxicities
  27. A Phase II Study Evaluating Glofitamab in Combination With Venetoclax Plus Zanubrutinib or Venetoclax Alone in Subjects With Untreated or Relapsed/Refractory High-risk Mantle-cell Lymphoma
  28. Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)
  29. Selinexor, Anti-PD-1 Antibody Plus Golidocitinib in R/R NKTCL
  30. Evaluating the Efficacy of Combined Cognitive Processing Therapy and Stellate Ganglion Blocks for PTSD
  31. Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
  32. A Phase 3 Open-label Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
  33. A Study to Investigate the Pharmacokinetics of Midazolam After Repeated Doses of Camizestrant (AZD9833) and to Investigate the Pharmacokinetics of Camizestrant When Administered Alone and in Combination With Carbamazepine in Healthy Post-Menopausal Female Participants

Phase 2-3:

  1. Cognitive Rehabilitation Following Breast Cancer Treatment
  2. Better Options for Chronic Cancer Pain
  3. A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

Phase 2:

  1. Phenotypes Associated With Constitutional EGFR Pathogenic Variants
  2. Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
  3. A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors
  4. Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer Survivors
  5. STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
  6. MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
  7. 18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
  8. Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
  9. Prostate Adaptive Radiation Therapy
  10. A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
  11. A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid Tumors
  12. A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer
  13. Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients
  14. Community Clinic Model to Improve Early Detection of Breast and Cervical Cancers in Kenya
  15. A Study of XS-02 Capsules in Patients With Advanced Solid Tumors
  16. The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
  17. Lung Cancer Screening Program in Mexico
  18. A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
  19. Oral Topotecan With Toripalimab for Patients With Endometrial Cancer
  20. Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy
  21. Study on the Staging and Prognosis Model of Bladder Cancer
  22. Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping
  23. Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer
  24. Stockholm3 Use Prior to MRI for Prostate Cancer Detection in a Clinical Care Pathway: a Multi-centered Validation
  25. MRD in High-risk EBC
  26. Registry for Esophageal and Gastroesophageal Junction Cancer
  27. TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
  28. The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women
  29. A Study of MOv18 IgE in Folate Receptor Alpha-expressing Platinum Resistant Ovarian Cancer
  30. Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer
  31. Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer
  32. Online Mindfulness-based Stress Reduction for Patients Receiving Chemotherapy
  33. An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer
  34. Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
  35. Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula
  36. Engage Psychosocial Intervention for Cancer Symptoms
  37. Strive Cardio for Endometrial Cancer Survivors
  38. A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice
  39. Evaluation of ADM(SC DermΒ® Recon) in Breast Reconstruction
  40. CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC
  41. Physical Activity and Sarcoma, Role and Impact on Outcome
  42. CIFeR - A Clinician-led Intervention to Address Fear of Cancer Recurrence
  43. The Effect of Health Belief Model-Based Cancer Education on Cancer Information Load, Knowledge and Attitudes Towards Cancer Screenings
  44. [18F]-rhPSMA PET-CT Imaging Performance in Patients with Prostate Cancer
  45. Single-layer Robot-assisted Transperitoneal Retroperitoneal Tubeless Radical Nephrectomy
  46. Silmitasertib (CX-4945) in Combination with Chemotherapy for Relapsed Refractory Solid Tumors
  47. XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer
  48. A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castrate-Resistant Prostate Cancer
  49. Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.
  50. Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1
  51. NON-COlorectal Liver METastases Undergoing Liver Resection
  52. A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
  53. Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases
  54. Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
  55. Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
  56. RCT Supportive Care Outpatient RIC HCT
  57. Immunonutrition and Psychosocial Factors in the Recovery of Patients After Gastrectomy: a Multidimensional Analysis
  58. Effect of Acupuncture on Opioid-associated Constipation in Cancer Patients
  59. Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
  60. Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
  61. Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer
  62. Clinical Study on the Safety and Efficacy of CAR-T/CAR-NK Cells in the Treatment of Recurrent Refractory or Unresectable Solid Tumors
  63. Developing a Whole-body MRI and Diffusion-weighted Imaging State-of-the-art Protocol: a Pilot Study
  64. Ziconotide for Non-cancer Pain by Intrathecal Administration
  65. Detection of G-quadruplex DNA Methylation in Cancer
  66. SynKIR-310 for Relapsed/Refractory B-NHL
  67. Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer
  68. Evaluating Respiratory Effects of Driving Pressure Guided Mechanical Ventilation Using Electrical Impedance Tomography in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy
  69. Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer
  70. End-of-life Decision-making Among Young Patients With Advanced Cancer: a Grounded Theory Approach
  71. High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer
  72. Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer
  73. 18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
  74. Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
  75. LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients
  76. Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases
  77. VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
  78. The Predictive Value of MRI for Adult-type Diffuse Gliomas
  79. Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
  80. A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer
  81. Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
  82. Investigation of Ξ²-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis
  83. Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
  84. Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
  85. B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers
  86. Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma
  87. Neoadjuvant Triple Therapy for Resectable HCC
  88. Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
  89. A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab
  90. The Impact of a Colonoscopy Monitoring Program on Endoscopists' Performance
  91. ALDOA Expression in Bladder Urothelial Carcinoma
  92. XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma
  93. Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
  94. Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
  95. A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant
  96. A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma
  97. MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma
  98. A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma
  99. CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors
  100. Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL
  101. Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy
  102. A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL).
  103. A Study of AZD0486 Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
  104. A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL
  105. A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People with Hairy Cell Leukemia (HCL)
  106. Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia
  107. Gene Therapy for B-Cell Acute Lymphoblastic Leukemia
  108. Oxygen Study-Orelabrutinib Combined With Obinutuzumab(O2) for First-Line Treatment of Marginal Zone Lymphoma
  109. Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia
  110. Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
  111. Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  112. A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL
  113. Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects
  114. Effect of Laser Acupuncture on Insulin Resistance in Obese Women With Polycystic Ovarian Syndrome

Phase 1-2:

  1. The 5-FU Holter Study
  2. A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
  3. Efficacy of Hypno-ear-acupuncture on Insomnia in Advanced Cancer Patients
  4. Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm
  5. A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
  6. Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors
  7. Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors
  8. Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer
  9. JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases
  10. Evaluation of Ultrasound-guided Transuterine Vaginal Biopsy Technique in Uterine Fibromatous Disease
  11. Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
  12. Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer
  13. Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung Cancer
  14. Effectiveness on Family Cohesion and Happiness of Using Social Media to Enhance Happiness Accounts for Late-Stage Cancer Patients and Their Families
  15. Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach（Radiogenomics-Urinary）
  16. Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDERΒ²S)
  17. Folate Study in Men With Advanced Prostate Cancer
  18. Effects of Exosome Adminstration in Preventing Early Leakage in Rectal Cancer Patients Undergoing Low Anterior Resection
  19. ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd
  20. The Lived Experiences of Persons With Early Stage Non-small Cell Lung Cancer and Their Significant Other(s) Following Surgery: a Rapid Ethnographic Approach
  21. Perioperative Immunotherapy for NSCLC (ECTOP-1030)
  22. Adjuvant Radiotherapy in High Risk Locally Advanced DTC
  23. TME Alteration in HER2 Positive Breast Cancer
  24. Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
  25. A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 1-49%
  26. A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
  27. A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients
  28. Study of YK012 in B-cell Acute Lymphoblastic Leukemia
  29. Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation
  30. Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women with Early-Stage Breast Cancer
  31. Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer
  32. Implication of Long Non-coding RNA HOTTIP Haplotype on Liver Cancer Metastasis
  33. Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
  34. Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk
  35. Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas
  36. Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
  37. Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
  38. Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma
  39. A Phase III Clinical Trial of High-dose Rituximab (500mg/mΒ²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL
  40. Theoretically Informed Behavioral Intervention
  41. The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China
  42. Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome

Phase 1:

  1. A Study of GSK5764227 in Participants With Advanced Solid Tumors
  2. Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients
  3. Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
  4. Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
  5. A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors.
  6. ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors
  7. Transportation for Cancer Care Navigation Tool for Reducing Travel Barriers Among Patients With Solid Tumors Receiving Radiation Therapy
  8. A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women With an Ovarian Mass
  9. Phase I Clinical Study to Evaluate the Safety and Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid Tumors
  10. Telephone Support in Advanced Gastrointestinal Cancer
  11. Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid Tumors
  12. A Prospective Cohort Study Comparing AI Prediction Model With Imaging Assessment to Diagnose Lymph Node Metastasis in Cervical Cancer
  13. CD8 PET Imaging in Metastatic Solid Tumours
  14. To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors
  15. Neoadjuvant Therapy in Cervical Cancer
  16. Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers
  17. Study of SYH2039 in Participants With Advanced Solid Tumors
  18. Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study
  19. Virtual Reality for Advanced Cancer Pain
  20. Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction
  21. Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma
  22. Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer
  23. A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
  24. A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
  25. Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
  26. Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
  27. Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
  28. Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.
  29. A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms
  30. De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers
  31. Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Radiogenomics-Liver）
  32. Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
  33. Preoperative Hemogram Parameters and BRAF Molecular Test Detected by Bethesda 3 Cytology.
  34. Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer
  35. Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
  36. SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
  37. Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
  38. Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
  39. MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
  40. Evaluation of On-Couch CBCT Image Quality
  41. Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases
  42. Online Adaptive Radiotherapy for Cervical Cancer
  43. First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients
  44. TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
  45. Conformal Sphincter-Preservation Operation Versus InterSphincteric Resection on Anal Function in Low Rectal Cancer
  46. Primary Tumor Resection for M1a Stage Lung Cancer
  47. Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer
  48. EB-OCT Biopsy Guidance of Lung Cancer
  49. Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
  50. Effects of a Single Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: Comparison of Paclitaxel vs Paclitaxel + Trastuzumab vs Paclitaxel + Carboplatine: the PROTECT-06 Bis Study
  51. An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UK
  52. Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
  53. Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity
  54. Clinical Evaluation of the Scopio Cell Morphology Technology
  55. Use of Artificial Intelligence in the Symptomatic BReAst Clinic SEtting
  56. ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
  57. Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study
  58. A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer
  59. Clinical Efficacy Study of Pucotenlimab Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
  60. A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008)
  61. Influence of Preoperative Vitamin D Level on Postoperative Pain in Breast Cancer Surgery Patients
  62. Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study
  63. PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC
  64. RESET-BRAIN: REhabilitation of SleEp and CogniTive Impairment in BReast Cancer Survivors Using an App-based Intervention
  65. Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
  66. Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens
  67. External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
  68. Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma
  69. A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma
  70. Intraoral Hypothermia Device for Preserving Taste During Radiation
  71. Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC
  72. Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
  73. OPTIMUS PRIME: Safety and Feasibility of OPTune GIOΒ® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
  74. The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage
  75. The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
  76. Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
  77. The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
  78. AK112 Plus AP Regimen for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma
  79. Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
  80. Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
  81. Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML
  82. Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
  83. Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
  84. Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia
  85. Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
  86. A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma
  87. MB-105 in Patients With CD5 Positive T-cell Lymphoma
  88. A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL
  89. A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
  90. A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma
  91. Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
  92. A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients
  93. A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
  94. Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
  95. FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Early Phase 1:

  1. Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)
  2. Rarecells Molecular Biomarkers for Early Detection of Lung Cancer
  3. First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
  4. Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
  5. Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
  6. A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
  7. Personalised Immunotherapy Platform
  8. The Effect of Complex DecongestΔ±ve Therapy on OxΔ±datΔ±ve Stress and AntΔ±oxΔ±dants
  9. Impact of Preoperative Endoscopic Ultrasound-guided Fine-needle Aspiration in Cholangiocarcinoma Patients

Phase Not Applicable:

  1. Histotripsy (HistoSonicsΒ®) for Liver Tumours
  2. The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model
  3. Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies
  4. The Effect of Acupressure on Patients Receiving Brachytherapy
  5. MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies
  6. Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor
  7. Evaluation of the Prognostic Impact of Decreased Serum beta2 Microglobulin in the First Year of Follow-up of Myeloproliferative Neoplasia (PRODIGE)
  8. The ctDNA-RECIST Trial Part One
  9. Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision
  10. A Study of ZW191 in Participants With Solid Tumors
  11. A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
  12. PICC-ports Versus Chest - Ports for Long Term Chemotherapy Deliverance in Oncology Patients
  13. Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
  14. Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
  15. Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer
  16. 22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions
  17. USPIO Enhanced MR Imaging in CNS Tumours (UMIC)
  18. Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies
  19. Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer
  20. Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
  21. Effects of Su Jok Seed Therapy Application on Pain, Anxiety and Psychological Resilience in Patients Hospitalized in the Oncology Ward
  22. Unique Treatment of Oncology Pain in Advanced Cancer
  23. Cervical Boost by Ablative Stereotactic Radiotherapy (SABR) vs Brachytherapy in Patients With Cervical Carcinoma
  24. A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
  25. Screening for Early Cervical Cancer Detection
  26. A Phase I Study of ONO-4538HSC in Subjects With Advanced or Metastatic Solid Tumors
  27. FDG-PET As an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis
  28. DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases
  29. Study of XB010 in Subjects With Solid Tumors
  30. Reirradiation Dose Escalation in Thoracic Cancers
  31. Cervical Cytology DNA Methylation for Cervical Cancer Screening
  32. Digital Training Module for Sustainable Education of Pediatric Oncology Nurses
  33. A Single-Center, Single-Arm Study of Neoadjuvant Short-Course Radiotherapy Concurrent With IL-2 Followed by Sequential Immunotherapy With CAPOX Combined With PD-1 Antibody and IL-2 for Locally Advanced Rectal Cancer
  34. A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
  35. Ixovex-1 Single Agent and Combination Therapy
  36. Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer
  37. A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
  38. Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.
  39. Testicular Adrenal Rest Tumor in Congenital Adrenal Hyperplasia Patients Attending Assuit University Children Hospital
  40. Digital Based Home Care Service for Ostomy Patients
  41. SPSIPB vs SAPB for Thoracoscopic Surgery
  42. Immersive Virtual Reality Based Exersice in Post-mastectomy Lymphedema Patients
  43. FAMILY Sleep Program
  44. Capillary Blood Accuracy
  45. Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
  46. HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes
  47. Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
  48. Hypofractionated Online Adaptive Radiotherapy of Breast Cancer
  49. The Effectiveness of E-health Intervention in Improving Mental Health Outcomes Among Breast Cancer Patients
  50. Danish Breast Cancer Group Internal Mammary Node Study
  51. Predicting Incidental Gallbladder Cancer
  52. The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung Cancer
  53. Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
  54. Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy
  55. Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
  56. TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
  57. Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)
  58. Fluzoparib Neoadjuvant Therapy for Ovarian Cancer
  59. Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer
  60. Repurposing Riluzole for Cancer-Related Cognitive Impairment: a Pilot Trial
  61. Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer
  62. Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation
  63. Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer
  64. Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
  65. Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs)
  66. Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer
  67. A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
  68. A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients
  69. VisR for Noninvasively Interrogating Stromal Collagen Organization as a Breast Cancer Biomarker: Evaluation of Compression in Control Subjects
  70. Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer
  71. Bortezomib Combined With PD-1 mAb and mFOLFIRINOX for Metastatic Pancreatic Cancer
  72. Chidamide and PD-1 Inhibitor Plus Anlotinib for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed
  73. Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC)
  74. ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
  75. Impact of Mortality Salience on Treatment Decisions
  76. Disitamab Vedotin (RC48) in Combination With AK104 (PD-1/CTLA-4 Bispecific) and Bevacizumab for the Treatment of Recurrent and Persistent Clear Cell Ovarian Cancer: a Single-arm, Phase II, Multicenter Study (DAB OCC Study)
  77. EndoStyle: Artificial Intelligence Image Transformation Tool for Colonoscopy
  78. Prediction Augmented Screening Initiative
  79. a Cohort Study (Gut Microbiota and HCC)
  80. Irinotecan Liposome in Combination With Capecitabine
  81. Clinical Study Evaluating the Effect of Losartan
  82. Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients
  83. HTA of NIVATS Based on RWE
  84. Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening
  85. Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma
  86. The Role of Levator Ani Muscle Reconstruction Technology in Urinary Incontinence Recovery
  87. Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants
  88. CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
  89. The Impact of PDD During TURB for NMIBC
  90. A Phase 2 Study of PCS6422 with Capecitabine in Patients with Advanced or Metastatic Breast Cancer
  91. Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment
  92. SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
  93. Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Pancreatectomy
  94. Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer with Different HER2 Expression Patterns
  95. A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
  96. A Phase β…Ά Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
  97. The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer
  98. FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer
  99. Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
  100. Advancing Lung Cancer Screening: Artificial Intelligence, Multimodal Imaging and Cutting-Edge Technologies for Early Detection and Characterization
  101. Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
  102. ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer
  103. Pyrotinib Combined With Trastuzumab Subcutaneously Compared Intravenous Administration in the Treatment of HER2-positive Early Breast Cancer
  104. A Phaseβ… Study of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer
  105. Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC
  106. A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
  107. Prediction of Local Recurrence and Its Impact on Long-term Outcomes After Low-risk Glans-sparing Surgery for Penile Squamous Cell Carcinoma
  108. Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma
  109. Contrast Between Traditional Regression Model and AI in Predicting Prolonged Stay Stay After Head and Neck Tumors
  110. Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Undergoing Anti-Aromatase Hormone Therapy
  111. The Effect of Interpersonal Relationships Psychotherapy on Breast Cancer Patients
  112. Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data
  113. Coenzyme Q10 and Chemotherapeutic Toxicity in Breast Cancer Patients
  114. Multidisciplinary Prehabilitation Management Pathway and Network Platform Construction
  115. T-DXd Versus THP for Medium-risk HER2-positive Early Breast Cancer
  116. Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer
  117. Comparison of Method for Skin Closure in Colorectal Cancer.
  118. Adaptive Therapy for Post-Second-Line Advanced Breast Cancer
  119. Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer
  120. QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
  121. A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
  122. LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)
  123. Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)
  124. Pilot Study of MPB-2043 Enhanced MRI for Nodal Staging in Head and Neck Squamous Cell Carcinomas
  125. RE002 T Cell Injection for the Treatment of KRAS G12D Mutated Solid Tumors
  126. Evaluation of the Clinical Effectiveness and Safety of Acellular Dermal Matrix(SC DERMΒ® Recon) in Breast Reconstruction
  127. Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI
  128. Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC
  129. Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
  130. Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer
  131. IGNITE Firefighters' Health
  132. A Study of MK-1084 With Midazolam and Digoxin in Healthy Participants (MK-1084-009)
  133. Effects of Aerobic Exercise on Cancer-Related Biomarkers, Functional Capacity, Cognitive Status and Quality of Life in Women With Breast Cancer
  134. Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
  135. Artificial Inteligence in Endoscopic Ultrasound
  136. Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients
  137. Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer
  138. Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
  139. What is the Optimal Training Model for Cervical Awareness?
  140. Opiophobia in Postsurgical Adults With Cancer
  141. End to End Anastomosis With Omega Suture Versus End to Anterior Rectal Wall In Colorectal Anastomosis in Sigmoid and Upper Rectal Cancer
  142. Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC
  143. Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer
  144. Safety of MT-401-OTS in Patients With Relapsed AML or MDS
  145. Study to Evaluate the Diagnostic Performance of of MAGENTIQ-COLO During Colonoscopy.
  146. Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors
  147. Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma
  148. Preoperative Planning With PSMA-PET in Melanoma Surgery Trial
  149. Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients
  150. eFLASH for Skin Lesions of Malignant Melanomas
  151. Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood
  152. Seroma and Hematoma Rates: MAXIGESIC IV vs. Ketorolac in Breast Cancer Surgery
  153. Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC
  154. Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma
  155. Ultrasound-guided Thoracic Interfascial Plane Nerve Block Versus Erector Spinae Plane Block for Pain Control After Modified Radical Mastectomy
  156. Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors
  157. Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer
  158. Confirmatory Study of PRGN-2012 in Patients with RRP
  159. Tka Assay for CDK4/6i
  160. Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients
  161. Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer
  162. C-Raven, a Virtual Tobacco Cessation Intervention in the Community
  163. Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC
  164. Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel
  165. An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
  166. Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)
  167. A Phaseβ… /β…΅ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
  168. Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients
  169. TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal Carcinoma
  170. Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.
  171. Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma
  172. Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)
  173. the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Hepatocellular Carcinoma
  174. SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma
  175. Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC
  176. Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients
  177. A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.
  178. De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC
  179. A Study of Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Radical Resection or Ablation
  180. The Safety and Efficacy of CD-801 in Patients With Advanced Intrahepatic Cholangiocarcinoma
  181. Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images
  182. RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR
  183. Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia
  184. External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease
  185. A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization
  186. DAratumumab and REvlimid REfractory MM
  187. ATRA and Carfilzomib in Plasma Cell Myeloma Patients
  188. A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
  189. Impact of Human Papillomavirus Carriage on IVF/ICSI Results (HPV AMP)
  190. Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients
  191. Study Comparing Therapy for Advanced Relapsed/refractory Multiple Myeloma with and Without Dexamethasone
  192. Epcoritamab, Zanubrutinib, and Rituximab (EZR) for R/R FL Relapsed or Refractory Follicular Lymphoma
  193. Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
  194. Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma
  195. Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
  196. Analgesic Efficacy of an Opioid-free Postoperative Pain Management Strategy Versus a Conventional Opioid-based Strategy Following Video-assisted Thoracoscopic Lobectomy
  197. Multi-antigen Specific CD8+ T Cells with Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients with Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation from a Matched Donor
  198. Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
  199. A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
  200. Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
  201. Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL
  202. CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
  203. Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
  204. Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
  205. Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL
  206. Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
  207. A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML
  208. Registry Study of Chinese Patients With Marginal Zone Lymphoma (MOTIVE)
  209. Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia
  210. Biomarkers of AKI in Patients Receiving Daratumumab
  211. DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
  212. Efficacy, Safety and Neural Mechanism of Stellate Ganglion Block in the Treatment of Anxiety. Disorder.
  213. A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults with Ocular Myasthenia Gravis


Note

The above Clinical Trial information has been retrieved from ClinicalTrials.gov